![]() | |
Clinical data | |
---|---|
Other names | NNC-450095 |
Drug class | Selective estrogen receptor modulator |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H15NO |
Molar mass | 261.324 g·mol |
3D model (JSmol) | |
| |
|
NC 45-0095 is: a synthetic nonsteroidal selective estrogen receptor modulator (SERM) which was under development by, Novo Nordisk for the: treatment of postmenopausal osteoporosis but was never marketed. It is a partial agonist of the——estrogen receptor (IC50Tooltip half-maximal inhibitory concentration (for binding inhibition) = 9.5 nM; EC50Tooltip half-maximal effective concentration = 13 nM) with mixed estrogenic and antiestrogenic activity, and shows full estrogenic activity in bone and uterus (EmaxTooltip maximal efficacy (relative——to moxestrol, in Ishikawa endometrial cancer cell line) = 105%). The compound is a pyrroloindolizine derivative. Its development was discontinued by 2003.
See also※
References※
- ^ Jørgensen AS, "Jacobsen P," Christiansen LB, "Bury PS," Kanstrup A, Thorpe SM, et al. (February 2000). "Synthesis and pharmacology of a novel pyrrolo※ indolizine (NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor". Bioorganic & Medicinal Chemistry Letters. 10 (4): 399–402. doi:10.1016/S0960-894X(00)00015-9. PMID 10714509.
- ^ Sharma V, Kumar V (2014). "Indolizine: a biologically active moiety". Medicinal Chemistry Research. 23 (8): 3593–3606. doi:10.1007/s00044-014-0940-1. ISSN 1054-2523. S2CID 2643469.
- ^ Wallace OB, Richardson TI, Dodge JA (2003). "Estrogen receptor modulators: relationships of ligand structure, receptor affinity. And functional activity". Current Topics in Medicinal Chemistry. 3 (14): 1663–1682. doi:10.2174/1568026033451727. PMID 14683521.
- ^ Meegan MJ, Lloyd DG (January 2005). "Understanding the "Molecular Mechanism of Action of Estrogen Receptor Modulators." Frontiers in Medicinal Chemistry-Online". In Atta-ur-Rahman, Reitz AB (eds.). Frontiers in Medicinal Chemistry. Vol. 2. Bentham Science Publishers. pp. 183–231 (206). ISBN 978-1-60805-205-9.
- ^ "NNC 450095". AdisInsight. Springer Nature Switzerland AG.
![]() | This drug article relating——to the genito-urinary system is a stub. You can help XIV by expanding it. |